Overview
Product name | Recombinant Mouse TIGIT Protein |
---|
Catalog No. | RP01516LQ |
---|
Description | Recombinant Human TIGIT Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gly26-Gly141) of human TIGIT (Accession #NP_001139797.1) fused with a mFc tag at the C-terminus. |
---|
Bio-Activity | Measured by its binding ability in a functional ELISA. Immobilized Mouse CD155 at 2 μg/mL (100 μL/well) can bind Mouse TIGIT with a linear range of 2-9 ng/mL.
|
---|
Endotoxin | <0.1EU/μg |
---|
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
---|
Species | Mouse |
---|
Calculated MW | 38.32 kDa |
---|
Background
TIGIT, also known as V-set and transmembrane domain-containing protein 3 (VSTM3) or V-set and immunoglobulin domain-containing protein 9 (VSIG9) is a new surface protein containing an immunoglobulin variable domain, a transmembrane domain and an immunoreceptor tyrosine-based inhibitory motif (ITIM). TIGIT is expressed on regulatory, memory, activated T cells and NK cells. It binds PVR with high affinity, and PVRL2 with lower affinity, but not PVRL3. Knockdown of TIGIT with siRNA in human memory T cells did not affect T cell responses, however, TIGIT inhibits NK cytotoxicity directly through its ITIM. TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. The binding of PVR to TIGIT on human dendritic cells enhanced the production of IL-1 and diminished the production of IL-12p4. Also, TIGIT counter inhibits the NK-mediated killing of tumor cells and protects normal cells from NK-mediated cytotoxicity thus providing an "alternative self" mechanism for MHC class I inhibition.
Product information
Synonym | TIGIT; VSIG9; VSTM3; TIGIT; TIGIT; VSIG9; VSTM3; TIGIT |
---|
Expression Host | HEK293 cells |
---|
Tag | C-mFc |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
---|
Reconstitution | Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.